Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Biobanking Technologies Market Status and Forecast (2016-2027)
  • 1.3.2 Global Biobanking Technologies Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Biobanking Technologies Supply by Company

• 2.1 Global Biobanking Technologies Sales Value by Company
• 2.2 Biobanking Technologies Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Biobanking Technologies Market Status by Category

• 3.1 Biobanking Technologies Category Introduction
  • 3.1.1 Blood Products
  • 3.1.2 Human Tissues
  • 3.1.3 Cell Lines
  • 3.1.4 Nucleic Acids
• 3.2 Global Biobanking Technologies Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Biobanking Technologies Market Status by End User/Segment

• 4.1 Biobanking Technologies Segment by End User/Segment
  • 4.1.1 Regenerative Medicine
  • 4.1.2 Life Science
  • 4.1.3 Clinical Research
• 4.2 Global Biobanking Technologies Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Biobanking Technologies Market Status by Region

• 5.1 Global Biobanking Technologies Market by Region
• 5.2 North America Biobanking Technologies Market Status
• 5.3 Europe Biobanking Technologies Market Status
• 5.4 Asia Pacific Biobanking Technologies Market Status
• 5.5 Central & South America Biobanking Technologies Market Status
• 5.6 Middle East & Africa Biobanking Technologies Market Status

6 North America Biobanking Technologies Market Status

• 6.1 North America Biobanking Technologies Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Biobanking Technologies Market Status

• 7.1 Europe Biobanking Technologies Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Biobanking Technologies Market Status

• 8.1 Asia Pacific Biobanking Technologies Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Biobanking Technologies Market Status

• 9.1 Central & South America Biobanking Technologies Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Biobanking Technologies Market Status

• 10.1 Middle East & Africa Biobanking Technologies Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Biobanking Technologies Market Forecast by Category and by End User/Segment

• 12.1 Global Biobanking Technologies Sales Value Forecast (2022-2027)
• 12.2 Global Biobanking Technologies Forecast by Category
• 12.3 Global Biobanking Technologies Forecast by End User/Segment

13 Global Biobanking Technologies Market Forecast by Region/Country

• 13.1 Global Biobanking Technologies Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Worthington
  • 14.1.1 Company Information
  • 14.1.2 Biobanking Technologies Product Introduction
  • 14.1.3 Worthington Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 VWR
  • 14.2.1 Company Information
  • 14.2.2 Biobanking Technologies Product Introduction
  • 14.2.3 VWR Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 TTP Labtech
  • 14.3.1 Company Information
  • 14.3.2 Biobanking Technologies Product Introduction
  • 14.3.3 TTP Labtech Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Thermo Fisher
  • 14.4.1 Company Information
  • 14.4.2 Biobanking Technologies Product Introduction
  • 14.4.3 Thermo Fisher Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Tecan Group
  • 14.5.1 Company Information
  • 14.5.2 Biobanking Technologies Product Introduction
  • 14.5.3 Tecan Group Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Qiagen
  • 14.6.1 Company Information
  • 14.6.2 Biobanking Technologies Product Introduction
  • 14.6.3 Qiagen Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Promega
  • 14.7.1 Company Information
  • 14.7.2 Biobanking Technologies Product Introduction
  • 14.7.3 Promega Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Panasonic
  • 14.8.1 Company Information
  • 14.8.2 Biobanking Technologies Product Introduction
  • 14.8.3 Panasonic Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Micronic
  • 14.9.1 Company Information
  • 14.9.2 Biobanking Technologies Product Introduction
  • 14.9.3 Micronic Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Merck
  • 14.10.1 Company Information
  • 14.10.2 Biobanking Technologies Product Introduction
  • 14.10.3 Merck Biobanking Technologies Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Hamilton
• 14.12 Greiner Bio One
• 14.13 Chart Industries
• 14.14 Brooks Automation
• 14.15 Biorep
• 14.16 Biokryo
• 14.17 Biobank
• 14.18 BD

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biobanking Technologies market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biobanking Technologies market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Blood Products
Human Tissues
Cell Lines
Nucleic Acids

Segmented by End User/Segment
Regenerative Medicine
Life Science
Clinical Research

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Worthington
VWR
TTP Labtech
Thermo Fisher
Tecan Group
Qiagen
Promega
Panasonic
Micronic
Merck
Hamilton
Greiner Bio One
Chart Industries
Brooks Automation
Biorep
Biokryo
Biobank
BD